Depocyte in the Treatment of CNS Relapse in Patients With Lymphoblastic Leucemia or Very Aggressive Lymphoma

NCT00388531 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Lymphoblastic Leukemia
Lymphoma

Interventions

DRUG: Depocyte®

Sponsor

PETHEMA Foundation